This is the information currently posted on the the clinical trails gov website regarding their diabetic foot ulcer study. Hopefully we'll get an update in the near future.
Study Type: Interventional (Clinical Trial) 1 EstimatedEnrollment: 138 participants 2 Allocation: Randomized 3 Intervention Model: Parallel Assignment 4 Masking: None (Open Label) 5 Primary Purpose: Treatment 6 Official Title: A Prospective, Multicenter, Open Label, Randomized, Controlled Clinical Study Evaluating the Effect of NovoSorb ® SynPath™ Dermal Matrix Compared to Standard of Care (SOC) In the Treatment of Nonresponsive, Chronic Diabetic Foot Ulcers. 7 ActualStudy Start Date: July 10, 2022 8 EstimatedPrimary Completion Date: December 1, 2023 9 EstimatedStudy Completion Date: March 1, 2024
- Forums
- ASX - By Stock
- PNV
- PNV - Banter and General Comments
PNV - Banter and General Comments, page-10865
-
-
- There are more pages in this discussion • 1,463 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.28 |
Change
-0.050(2.15%) |
Mkt cap ! $1.609B |
Open | High | Low | Value | Volume |
$2.27 | $2.30 | $2.27 | $227.6K | 99.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 3069 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 11884 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 25620 | 2.270 |
14 | 54011 | 2.260 |
8 | 11407 | 2.250 |
10 | 19237 | 2.240 |
8 | 55231 | 2.230 |
Price($) | Vol. | No. |
---|---|---|
2.280 | 1709 | 6 |
2.290 | 13692 | 11 |
2.300 | 36559 | 13 |
2.310 | 13074 | 8 |
2.320 | 50660 | 8 |
Last trade - 10.17am 09/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |